Remus Pharmaceuticals Limited — Important, 17-05-2025: General Updates
17-05-2025 | 07:14 pm
17-05-2025 | 07:14 pm
Remus Pharmaceuticals has announced a board meeting to discuss material events and disclosures. Key managerial personnel, including the MD, WTD, and CFO, have been designated to assess the significance of events and oversee communication. The Company Secretary will manage stock exchange filings. No operational or financial impact was indicated.
No comments yet. Be the first to comment!
